Evercore Wealth Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Evercore Wealth Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8	Closed	-$18K	–	1062
2015 Q2	$18K	Hold	8	–	–	﹤0.01%	818
2015 Q1	$24K	Hold	8	–	–	﹤0.01%	760
2014 Q4	$26K	Hold	8	–	–	﹤0.01%	632
2014 Q3	$28K	Sell	8 -7	-47%	-$27.2K	﹤0.01%	689
2014 Q2	$60K	Hold	15	–	–	﹤0.01%	586
2014 Q1	$62K	Hold	15	–	–	﹤0.01%	566
2013 Q4	$58K	Hold	15	–	–	﹤0.01%	539
2013 Q3	$60K	Hold	15	–	–	﹤0.01%	555
2013 Q2	$152K	Buy	+15	New	+$166K	0.01%	433

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Evercore Wealth Management's FRTX Position: Q3 2015 in Review

Evercore Wealth Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2015, closing a stake of 8 shares — an estimated $18K sold.

Evercore Wealth Management first reported a position in FRTX in Q2 2013 and held it in 9 quarters. The position peaked at $152K in Q2 2013. 49 funds tracked by Wall St. Rank hold FRTX as of Q3 2015.

Evercore Wealth Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Evercore Wealth Management sold 8 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $18K.
Evercore Wealth Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
Evercore Wealth Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $152K in Q2 2013.
49 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Evercore Wealth Management's 13F filing for Q3 2015, filed 16 Nov 2015.